PIK3R1
Phosphatidylinositol 3-kinase regulatory subunit alpha
Also known as: GRB1, p85, p85-ALPHA, P85A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P27986
- Gene
- PIK3R1
- Ensembl
- ENSG00000145675
- Chromosome
- 5
- Canonical length
- 724 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. This gene encodes the 85 kD regulatory subunit. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in this gene has been associated with insulin resistance. Alternative splicing of this gene results in four transcript variants encoding different isoforms. [provided by RefSeq, Jun 2011]
Canonical amino-acid sequenceUniProt
724 residues, UniProt reviewed canonical sequence.
>P27986|PIK3R1
1 MSAEGYQYRA LYDYKKEREE DIDLHLGDIL TVNKGSLVAL GFSDGQEARP EEIGWLNGYN
61 ETTGERGDFP GTYVEYIGRK KISPPTPKPR PPRPLPVAPG SSKTEADVEQ QALTLPDLAE
121 QFAPPDIAPP LLIKLVEAIE KKGLECSTLY RTQSSSNLAE LRQLLDCDTP SVDLEMIDVH
181 VLADAFKRYL LDLPNPVIPA AVYSEMISLA PEVQSSEEYI QLLKKLIRSP SIPHQYWLTL
241 QYLLKHFFKL SQTSSKNLLN ARVLSEIFSP MLFRFSAASS DNTENLIKVI EILISTEWNE
301 RQPAPALPPK PPKPTTVANN GMNNNMSLQD AEWYWGDISR EEVNEKLRDT ADGTFLVRDA
361 STKMHGDYTL TLRKGGNNKL IKIFHRDGKY GFSDPLTFSS VVELINHYRN ESLAQYNPKL
421 DVKLLYPVSK YQQDQVVKED NIEAVGKKLH EYNTQFQEKS REYDRLYEEY TRTSQEIQMK
481 RTAIEAFNET IKIFEEQCQT QERYSKEYIE KFKREGNEKE IQRIMHNYDK LKSRISEIID
541 SRRRLEEDLK KQAAEYREID KRMNSIKPDL IQLRKTRDQY LMWLTQKGVR QKKLNEWLGN
601 ENTEDQYSLV EDDEDLPHHD EKTWNVGSSN RNKAENLLRG KRDGTFLVRE SSKQGCYACS
661 VVVDGEVKHC VINKTATGYG FAEPYNLYSS LKELVLHYQH TSLVQHNDSL NVTLAYPVYA
721 QQRRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIK3R1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 117 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 117 nTPM
- liver: 101 nTPM
- breast: 91 nTPM
- heart muscle: 73 nTPM
- cerebral cortex: 73 nTPM
- smooth muscle: 70 nTPM
Single-cell type
- thymic myoid cells: 775 nCPM
- nk-cells: 628 nCPM
- oligodendrocyte progenitor cells: 579 nCPM
- schwann cells: 571 nCPM
- fibro-adipogenic progenitors: 480 nCPM
- t-cells: 470 nCPM
Immune cell
- basophil: 24 nTPM
- naive CD4 T-cell: 17 nTPM
- MAIT T-cell: 14 nTPM
- memory CD4 T-cell: 14 nTPM
- eosinophil: 13 nTPM
- naive CD8 T-cell: 12 nTPM
Brain region
- cerebral cortex: 230 nTPM
- white matter: 170 nTPM
- basal ganglia: 167 nTPM
- midbrain: 150 nTPM
- thalamus: 143 nTPM
- amygdala: 131 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PIK3R1.
Disease | AllUniProt
Conditions PIK3R1 is implicated in, by any mechanism.
- Agammaglobulinemia 7, autosomal recessive (AGM7) MIM:615214
- SHORT syndrome (SHORTS) MIM:269880
- Immunodeficiency 36 with lymphoproliferation (IMD36) MIM:616005
Disease | GeneticClinVar
78 pathogenic / likely-pathogenic of 755 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- SHORT syndrome
- Immunodeficiency 36 with lymphoproliferation
- Agammaglobulinemia 7, autosomal recessive
- Vascular malformation
- Vascular Malformations and Overgrowth
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.72
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell differentiation
- cellular response to insulin stimulus
- cellular response to UV
- cytokine-mediated signaling pathway
- extrinsic apoptotic signaling pathway via death domain receptors
- growth hormone receptor signaling pathway
- immune response
- insulin receptor signaling pathway
- insulin-like growth factor receptor signaling pathway
- interleukin-18-mediated signaling pathway
- intracellular glucose homeostasis
- intrinsic apoptotic signaling pathway in response to DNA damage
- myeloid leukocyte migration
- natural killer cell mediated cytotoxicity
- negative regulation of apoptotic process
- negative regulation of cell-matrix adhesion
- negative regulation of osteoclast differentiation
- negative regulation of stress fiber assembly
- osteoclast differentiation
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- phosphatidylinositol phosphate biosynthetic process
- positive regulation of D-glucose import
- positive regulation of endoplasmic reticulum unfolded protein response
- positive regulation of filopodium assembly
- positive regulation of focal adhesion disassembly
- positive regulation of lamellipodium assembly
- positive regulation of leukocyte migration
- positive regulation of protein import into nucleus
- positive regulation of protein localization to plasma membrane
- positive regulation of RNA splicing
- positive regulation of smooth muscle cell proliferation
- positive regulation of transcription by RNA polymerase II
- positive regulation of tumor necrosis factor production
- protein import into nucleus
- protein polyubiquitination
- protein stabilization
- regulation of toll-like receptor 4 signaling pathway
- response to endoplasmic reticulum stress
- substrate adhesion-dependent cell spreading
- T cell differentiation
- T follicular helper cell differentiation
- transcription by RNA polymerase II
Molecular functions
- 1-phosphatidylinositol-3-kinase regulator activity
- enzyme-substrate adaptor activity
- ErbB-3 class receptor binding
- GTPase activator activity
- insulin binding
- insulin receptor binding
- insulin receptor substrate binding
- insulin-like growth factor receptor binding
- kinase activator activity
- neurotrophin TRKA receptor binding
- phosphatidylinositol 3-kinase activator activity
- phosphatidylinositol 3-kinase binding
- phosphatidylinositol 3-kinase regulator activity
- phosphatidylinositol 3-kinase regulatory subunit binding
- phosphatidylinositol kinase activity
- phosphotyrosine residue binding
- protein heterodimerization activity
- protein phosphatase binding
- transmembrane receptor protein tyrosine kinase adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Rho GTPase-activating protein domain
- SH2 domain
- SH3 domain
- Rho GTPase activation protein
- PI3K regulatory subunit p85-related , inter-SH2 domain
- PI3K p85 subunit, C-terminal SH2 domain
- PI3K p85 subunit, N-terminal SH2 domain
- SH3-like domain superfamily
- SH2 domain superfamily
- SH2 domain
- RhoGAP domain
- Phosphatidylinositol 3-kinase regulatory subunit P85 inter-SH2 domain
- Phosphatidylinositol 3-kinase regulatory subunit alpha, SH3 domain
- PIK3R1, inter-SH2 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PIK3R1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIK3R1 as an antibody target. Whether an autoantibody or antibody against PIK3R1 could matter depends on whether native PIK3R1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIK3R1 is annotated at the cell surface, where native PIK3R1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PIK3R1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...